Article info
Editorial commentary
MOG-IgG serological status matters in paediatric ADEM
- Correspondence to Dr Tatsuro Misu, Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai 980-8574, Japan; misu{at}med.tohoku.ac.jp
Citation
MOG-IgG serological status matters in paediatric ADEM
Publication history
- Received July 18, 2014
- Accepted July 19, 2014
- First published August 18, 2014.
Online issue publication
February 12, 2015
Article Versions
- Previous version (18 August 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions